Feasibility of connecting regional research programs to national multisite trials emanating from the CTSA Trial Innovation Network. Issue 2 (24th April 2020)

• Record Type: Journal Article
• Authors: Hassell, Laurie; Gregor, Charlie; Melvin, Ann; Goss, Christopher; Coker, Robert H.; Laukes, Cindi; Albritton, Sandra; Brant, Jeannine; Amoroso, Paul; Whitener, Nichole; Tuttle, Katherine R.
• Is Part Of: Journal of clinical and translational science. Volume 4:Issue 2(2020)
• Page Start: 75
• Page End: 80
• Publication Date: 2020-04-24
• Subjects: Translational research, -- clinical research network, -- clinician-engaged research, -- multisite clinical trials, -- community-academic partnership; Clinical medicine -- Research -- Periodicals; Medicine, Experimental -- Periodicals; Human experimentation in medicine -- Periodicals; 616.027
• DOI: 10.1017/cts.2019.437
• Languages: English
• ISSNs: 2059-8661

Abstract

Abstract: A collaborative research model was developed and tested to enable regional healthcare systems to join multisite clinical trials emanating from the Clinical and Translational Science Award (CTSA) Trial Innovation Network (TIN) by the Institute of Translational Health Sciences at the University of Washington and the Northwest Participant and Clinical Interactions (NW PCI) Network. The NW PCI is a collaborative group of regional research programs located at medical centers, healthcare systems, and universities across Washington, Wyoming, Alaska, Montana, and Idaho. This article describes the purpose, development, barriers, and initial experience with feasibility assessment for TIN-supported studies in the NW PCI. The tools and processes of the NW PCI Network were adapted to enable network sites to assess studies for clinical relevance and feasibility. Seven of seventeen TIN-supported studies were reviewed for consideration; three of which resulted in successful completion of study documentation for site selection by NW PCI sites. The NW PCI/TIN model can be adapted by other CTSAs to increase involvement of regional research programs in national multisite clinical research studies. Barriers to expanding TIN-supported trials to regional networks include short timelines for study document submissions, insufficient site reimbursement rates, and non-feasible study designs.